Abstract:Abstract Krüppel-like factor 5 (KLF5) is an evolutionarily conserved zinc finger-containing transcription factor promoting breast cell proliferation, survival, and tumor growth through upregulating its target gene FGF-BP. The protein abundance of KLF5 has been shown to be strictly regulated at transcriptional and posttranslational levels. Our previous studies suggest that the KLF5 protein degradation is through the ubiquitin proteasome pathway. The WWP1 E3 ligase can target KLF5 for ubiquitin-mediated proteasomal degradation. In this study, we demonstrated the F-box protein FBW7 targets KLF5 for proteolysis and suppresses KLF5's functions in breast cancer. The SCFFBW7 (SKP1-Cullin1-F-box) E3 ligase complex has been shown to target several oncoproteins, including MYC and CyclinE, for proteolysis. FBW7 could be a tumor suppressor due to its frequent mutations in multiple cancers. Here, we first demonstrated that inactivation of endogenous FBW7 by gene knockout, knockdown, or mutation remarkably increases the endogenous KLF5 protein abundances through blocking its degradation in multiple cell lines. Second, we found that overexpression of FBW7 decreases the exogenous and endogenous KLF5 protein levels in HEK293T and SUM149PT cell lines. Functionally, overexpression of FBW7 in the endogenous FBW7 mutated SUM149PT cells decreases the FGF-BP gene expression and the DNA synthesis. Importantly, knockdown of endogenous Fbw7 increases the FGF-BP gene expression, cell proliferation, and survival through upregulating the KLF5 expression in breast cells. These findings suggest that the Fbw7 tumor suppressor inhibit breast cancer cell proliferation and survival at least partially through targeting KLF5 for ubiquitin-mediated degradation. This new regulatory mechanism of KLF5 degradation may result in useful diagnostic and therapeutic targets for breast cancer and other cancers. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3155.

FBW7 Loss Promotes Epithelial-to-mesenchymal Transition in Non-Small Cell Lung Cancer Through the Stabilization of Snail Protein.

Mir-223/Fbw7 Axis Regulates Doxorubicin Sensitivity Through Epithelial Mesenchymal Transition in Non-Small Cell Lung Cancer.

Functional Characterization of FBXL7 As a Novel Player in Human Cancers

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.

Emerging Roles of the FBW 7 Tumour Suppressor in Stem Cell Differentiation

FBW7 Increases Chemosensitivity in Hepatocellular Carcinoma Cells Through Suppression of Epithelial-Mesenchymal Transition.

Fbw7 Suppresses Metastasis Of Colorectal Cancer By Inhibiting Hif1 Alpha/Ceacam5 Functional Axis

FBW7 Suppresses Cell Proliferation and G2/M Cell Cycle Transition Via Promoting Γ-Catenin K63-linked Ubiquitylation.

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2

FBXL10 Promotes EMT and Metastasis of Breast Cancer Cells Via Regulating the Acetylation and Transcriptional Activity of SNAI1

Data from Targeting FBW7 As a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Upregulation of FBXW7 Suppresses Renal Cancer Metastasis and Epithelial Mesenchymal Transition.

Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase

FBXW2 Suppresses Migration and Invasion of Lung Cancer Cells Via Promoting Β-Catenin Ubiquitylation and Degradation

FBXO11 Promotes Ubiquitination of the Snail Family of Transcription Factors in Cancer Progression and Epidermal Development

Abstract 3155: the SCFFBW7 E3 Ubiquitin Ligase Targets Krüppel-like Factor 5 (KLF5) for Proteolysis in Breast Cancer

Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation

FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation

Fbxw7 Regulates Tumor Apoptosis, Growth Arrest and the Epithelial-to-mesenchymal Transition in Part Through the RhoA Signaling Pathway in Gastric Cancer.

FBXW7 in breast cancer: mechanism of action and therapeutic potential

Clinical significance of FBXW7 loss of function in human cancers